2003
DOI: 10.1016/s1062-1458(03)00274-5
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
76
0

Year Published

2003
2003
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(78 citation statements)
references
References 0 publications
2
76
0
Order By: Relevance
“…In comparisons between groups, blacks respond slightly better than whites to diuretics and CCBs, while whites respond slightly better than blacks to ACE inhibitors and β-blockers. More recent data on lisinopril, quinapril and losartan support the differences with ACE inhibitors and ARBs suggested by the meta-analysis 36-38…”
Section: Ethnic Differences In Responses To Antihypertensive Therapiesmentioning
confidence: 83%
“…In comparisons between groups, blacks respond slightly better than whites to diuretics and CCBs, while whites respond slightly better than blacks to ACE inhibitors and β-blockers. More recent data on lisinopril, quinapril and losartan support the differences with ACE inhibitors and ARBs suggested by the meta-analysis 36-38…”
Section: Ethnic Differences In Responses To Antihypertensive Therapiesmentioning
confidence: 83%
“…[21][22][23][24][25] Furthermore, race can influence the efficacy profile of various therapeutic agents. [26][27][28][29] Some of the hypotheses to explain these racial differences in the prevalence of disease and the response to treatment have included genetic polymorphisms, differences in SES, and disparities in healthcare use. A better understanding of the role of race on treatment modalities will require inclusion and reporting of race in clinical studies along with subgroup analysis by race.…”
mentioning
confidence: 99%
“…Increases serum aldosterone and plasma renin levels; [19][20][21][22] but this does not overcome the antihypertensive effects [14,19] Causes natriuresis with increased sodium excretion and decreased potassium excretion [12,23] Reduces vascular/myocardial fibrosis and cardiac hypertrophy in animal models of cardiac injury, possibly independently of effects on BP [16,[24][25][26] Improves endothelial dysfunction and attenuates the effects of vasoactive mediators on vascular endothelium in rodent/rabbit models [15,27,28] Increases vascular compliance in patients with hypertension [29] Reduces left ventricular mass in patients with hypertension and left ventricular hypertrophy [30] Reduces proteinuria in patients with hypertension [29][30][31][32][33] reduced free radical stress in a rabbit model of diet-induced atherosclerosis [27] (see also section 2.4.2). affinities 5.1 × 10 -3 vs 1.1 × 10 -1 ).…”
Section: Pharmacodynamic Effectsmentioning
confidence: 99%
“…hypertension [30][31][32][33]42] (see section 4.3.2 for details). As would be expected given their different mechanisms of…”
Section: Effects On the Kidneymentioning
confidence: 99%